Skip to main content
WeRide Inc. logo

WeRide Inc. — Investor Relations & Filings

Ticker · 800 LEI · 254900R1B7IWBCPDQ262 HKEX Transportation and storage
Open in API
Filings indexed 1,066 across all filing types
Latest filing 2003-10-27 Earnings Release
Country KY Cayman Islands
Listing HKEX 800

About WeRide Inc.

http://www.weride.ai

WeRide Inc. is a commercial-stage global technology leader specializing in the research, development, and large-scale deployment of autonomous driving solutions, ranging from Level 2 (WePilot 3.0 ADAS) to Level 4 capabilities. The company offers a comprehensive portfolio of autonomous vehicles designed for various mobility and logistics applications, including Robotaxi, Robobus, Robovan, and Robosweeper. WeRide is recognized as a pioneer in the industry, operating in over 40 cities across 11 countries and holding autonomous driving permits in seven countries globally. Its core products, such as the Robotaxi, have launched large-scale commercial operations in regions like China and the UAE. WeRide leverages its proprietary technology stack to deliver safe, reliable, and scalable driverless solutions for urban transformation.

Recent filings

Filing Released Lang Actions
Results Announcement (Summary)
Earnings Release Classification · 98% confidence The document is a summary of financial results for Far East Pharmaceutical Technology Co., Limited, covering the fiscal year ending 30/06/2003. It provides key financial metrics such as turnover, profit, EPS, and dividend information. While it contains detailed financial data, it is presented as a summary announcement of results rather than the full annual report (10-K) or a standalone earnings release (ER). Given the structure and content, it fits the definition of an Earnings Release (ER) as it provides the initial announcement of financial results with key highlights. FY 2003
2003-10-27 English
Share Subdivision
Share Issue/Capital Change Classification · 100% confidence The document announces a share subdivision (1 into 4) for Far East Pharmaceutical Technology Company Limited, which involves a change in the capital structure and share denomination. This falls under the category of share issues or capital changes.
2003-10-24 English
Circular (Proposal for Subdivision of Shares and Change in Board Lot Size of Shares)
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a circular from Far East Pharmaceutical Technology Company Limited regarding a proposal for subdivision of shares and change in board lot size. It includes details about an extraordinary general meeting (EGM) to approve the share subdivision, expected timetable for trading and exchange of share certificates, and explanations from the board. The document is not a financial report, earnings release, or audit report. It is a detailed communication to shareholders about a corporate action requiring shareholder approval at an EGM. This type of document is best classified as a Proxy Solicitation & Information Statement (PSI), as it provides information to shareholders to solicit their votes for the meeting resolution.
2003-10-22 English
Announcement
Share Issue/Capital Change Classification · 100% confidence The document is an announcement from Far East Pharmaceutical Technology Company Limited regarding a proposal for subdivision of shares and change in board lot size. It details the reasons, effects, conditions, and timetable for the share subdivision, including shareholder approval and stock exchange listing permissions. There are no financial statements or detailed financial performance data presented. The document is not a report but an announcement of a corporate action related to share capital structure. This fits the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues, stock splits, or other capital changes such as share subdivisions.
2003-10-08 English
Announcement
Capital/Financing Update Classification · 95% confidence The document is an announcement made by Far East Pharmaceutical Technology Company Limited regarding the entering into of a Loan Agreement for a 3-year unsecured loan facility of US$3,000,000. It details the terms of the loan, including conditions related to the chairman's position and shareholding requirements. The announcement references compliance with disclosure obligations under Practice Note 19 of the Listing Rules of the Stock Exchange of Hong Kong. The document is not a financial report, audit report, or earnings release, nor does it contain financial statements or detailed financial data. It is a regulatory disclosure about a financing event and related undertakings, which fits the category of Capital/Financing Update (CAP). The document length is 4865 characters, which is sufficient to contain substantive information rather than a mere report publication announcement. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2003-05-21 English
Announcement
Capital/Financing Update Classification · 95% confidence The document is an announcement made by Far East Pharmaceutical Technology Company Limited regarding a loan agreement entered on 7th May 2003 with a syndicate of banks for a 3-year unsecured loan facility of US$31,000,000. It details the terms of the loan, including conditions related to the chairman and major shareholder, and the consequences of default. The announcement is made pursuant to Practice Note 19 of the Listing Rules, which relates to disclosure obligations for loan agreements and similar financing arrangements. The document does not contain financial statements or detailed financial performance data, nor is it a transcript, report, or presentation. It is a regulatory disclosure about financing terms and compliance with listing rules. Therefore, it fits best under Capital/Financing Update (CAP). The document length is about 4854 characters, which is sufficient for a substantive announcement rather than a brief notice. Hence, the classification is CAP with high confidence.
2003-05-07 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.